ANIP
ANIP
NASDAQ · Pharmaceuticals

Ani Pharmaceuticals Inc

$79.49
-1.03 (-1.28%)
As of Jun 21, 10:05 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target -53.8% upside
Low Target $28.36
Average Target $36.71
High Target $54.52
Current Price $79.49
Current
$79.49
Target
$36.71
$28.36 $36.71 avg $54.52
Scenario Analysis
Bear Case
$28.36
-64.3%
Low target
Base Case
$36.71
-53.8%
Avg target
Bull Case
$54.52
+-31.4%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$99.50
-20.1% from high
52-Week Low
$62.61
+27.0% from low
Target vs 52W High
$36.71
-63.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%